Octreotidă Teva (Octreotide Acetate)

Octreotide acetate, the active ingredient in Octreotidă Teva, is a synthetic somatostatin analog presented as a solution for subcutaneous injection use. It regulates hormone secretion and is employed in the management of certain endocrine tumors and related conditions.

GNH USA supplies Octreotidă Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Octreotide acetate acts through the somatostatin pathway and offers clinical benefits in several endocrine‑related disorders.

- Acromegaly: reduces the excess growth hormone and IGF‑1 levels. - Carcinoid syndrome: controls the flushing and diarrhea associated with serotonin release and reduces serotonin production. - VIP treatment of VIP‑  ".". -  ". \